Ticker Details
United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.
IPO Date:	June 17, 1999
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$23.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.88 | 1.44%
Avg Daily Range (30 D):	$4.91 | 0.89%
Avg Daily Range (90 D):	$7.41 | 1.36%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.42M

Trade Size
Avg Trade Size (Sh.):	93
Avg Trade Size (Sh.) (30 D):	25
Avg Trade Size (Sh.) (90 D):	24

Institutional Trades
Total Institutional Trades:	14,628
Avg Institutional Trade:	$5.67M
Avg Institutional Trade (30 D):	$43.2M
Avg Institutional Trade (90 D):	$37.58M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$10.95M
Avg Closing Trade (30 D):	$67.36M
Avg Closing Trade (90 D):	$52.03M
Avg Closing Volume:	59.86K

News

Jun 30, 2026 @ 4:26 AM Big Pharma Has a Case of Merger Mania Source: Motley Fool Staff

Jun 10, 2026 @ 6:17 PM iShares U.S. Pharmaceuticals ETF Tops Simplify Hea... Source: Brendan Coffey

Jun 9, 2026 @ 3:10 PM These 3 Stocks Lowered Their Share Counts Drastica... Source: Leo Miller

May 19, 2026 @ 5:00 PM Pulmonary Arterial Hypertension Clinical Trial Pip... Source: Delveinsight

May 5, 2026 @ 12:00 PM Transplants.org Launches as Centralized Education ... Source: Not Specified

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$29.27	$6.32
Diluted EPS	$27.07	$5.82
Revenue	$3.17B	$781.5M
Gross Profit	$2.74B	$648.1M
Net Income / Loss	$1.29B	$274.9M
Operating Income / Loss	$1.44B	$325.8M
Cost of Revenue	$425.3M	$133.4M
Net Cash Flow	$-620.2M	$-277.4M
PE Ratio

Splits
Sep 23, 2009	2:1